| Business Summary | | Nurescell
Inc.
was
formed
for
the
purpose
of
developing
and
commercially
exploiting
a
proprietary
radiation
shielding
technology
(the
Nurescell
Technology)
for
use
by
the
nuclear
power
industry
and
others
producing,
handling
or
storing
radioactive
materials.
The
Nurescell
Technology
material
is
designed
for
incorporation
into
the
structural
components
of
new
and
existing
nuclear
reactors
and
other
facilities
in
order
to
provide
a
cost-effective
safeguard
from
the
lethal
effect
of
radiation
while
achieving
a
minimal
disruption
to
existing
facilities.
It
is
also
designed
as
a
containment
material
that
will
provide
an
attractive
alternative
to
the
conventional
technologies
currently
used
to
transport
and
store
ever-increasing
amounts
of
spent
nuclear
fuel
and
other
radioactive
waste.
In
addition,
it
is
expected
to
provide
an
innovative
shielding
material
for
various
other
purposes,
including
nuclear
accelerator
and
defense
research
applications. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Nurescell,
Inc.
was
formed
for
the
purpose
of
developing
and
commercially
exploiting
a
proprietary
radiation
shielding
technology
for
use
by
the
nuclear
power
industry
and
others
producing,
handling
or
storing
radioactive
materials.
For
the
fiscal
year
ended
3/31/01,
revenues
fell
43%
to
$5
thousand.
Net
loss
fell
84%
to
$1
million.
Results
reflect
a
decrease
in
sales.
Lower
loss
reflects
lower
SG&A
expenses
and
a
$280
thousand
gain
on
the
conversion
of
debt. | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| John Longenecker, 50 Pres,
CEO, Director | $56K | James Samuelson, 31 CFO,
VP, Sec., Director | -- | Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|